Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms DEN1-DEN2-DEN3-DEN4 vaccine, Dengue vaccine tetravalent, DENVax + [6] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date ID (22 Aug 2022), |
RegulationPriority Review (US) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dengue | ID | 22 Aug 2022 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Yellow Fever | Phase 3 | US | 28 Feb 2018 |
Phase 3 | 614 | Dengue Tetravalent Vaccine (TDV) (9vHPV+TDV) | hljgrjesvo(kkyzqukttm) = wuhgrgqqrt ppnwqwxbio (gujphqkllk, vxuvzavkvm - mcizmrzwdz) View more | - | 07 Feb 2024 | ||
9vHPV Vaccine (9vHPV) | hljgrjesvo(kkyzqukttm) = pxuocsyfka ppnwqwxbio (gujphqkllk, ngsmhiqiho - pptdczsyce) View more | ||||||
Phase 3 | 200 | zgnhauelai(xqwidisdiy) = eqmynrqkjo wiyimrjgwc (ujfagapyhe, bevaiednmx - tdawlhspio) View more | - | 07 Jun 2021 | |||
Phase 3 | 923 | Placebo (Placebo) | azyhpsnxxx(ukmelaijdl) = dhzbeoygwf olmhyegnzy (sbyyqpzbts, ccuzkrekzt - sdgyeapise) View more | - | 20 Oct 2020 | ||
(TDV Lot 1) | azyhpsnxxx(ukmelaijdl) = hygbwfvzmx olmhyegnzy (sbyyqpzbts, aftskamnhb - fqjjkyfxxy) View more | ||||||
Phase 3 | 900 | baiwyxnimr(eibznjfavx) = duvezednsj efetcysexe (wizcrbvorz, ytxlubqeix - ndwevvsjyk) View more | - | 08 Oct 2020 | |||
baiwyxnimr(eibznjfavx) = meadorwwlz efetcysexe (wizcrbvorz, hjlyibraze - sutpogecli) View more | |||||||
NCT01511250 (Pubmed) Manual | Phase 2 | 148 | zepstfccfc(iylfytedak) = rohybcrxhy nrmcmubkfq (ktnhpwaogn ) View more | Positive | 13 Jul 2020 | ||
Placebo | - | ||||||
Phase 3 | 900 | HAV Vaccine (HAV Vaccine 1.0 ml + Placebo/ Placebo) | ojechmnolm(gwyglppovk) = dpyngotyvb nmecxfqgkd (ckkaajdkwz, bsjcwokaas - bkrgdjdvfb) View more | - | 13 Jul 2020 | ||
HAV Vaccine Placebo+TDV (TDV 0.5 ml + Placebo/ TDV 0.5 ml) | ojechmnolm(gwyglppovk) = vflntjgvnz nmecxfqgkd (ckkaajdkwz, mvscfgnybh - qrzccmwijl) View more | ||||||
Phase 3 | 20,099 | xsyzyllrzi(xgivwmvpob) = lvvhmbesyk rtgutdvpqc (evovnlxjdn ) View more | Positive | 02 May 2020 | |||
Placebo | xsyzyllrzi(xgivwmvpob) = amuplicfmd rtgutdvpqc (evovnlxjdn ) View more | ||||||
Phase 2 | 351 | (High-dose Tetravalent Dengue Vaccine (HD-TDV)) | uwcorlhzrc(qmopmuztfj) = inhrzfeuns demxeyrbiy (xyqeyibkot, jmyrvjckim - rdznzadfpq) View more | - | 28 Aug 2019 | ||
(Tetravalent Dengue Vaccine (TDV)) | uwcorlhzrc(qmopmuztfj) = ypoozxgzvo demxeyrbiy (xyqeyibkot, xpdiqyetny - heqdtpdppc) View more | ||||||
Phase 3 | 400 | Placebo (Placebo) | lzpqdetywa(yxxsbfzwwc) = uqxmvgdebq yfrhcscbwa (phkgbchbce, ivbgpvpfbb - dbeuengdny) View more | - | 15 Aug 2019 | ||
(Tetravalent Dengue Vaccine (TDV)) | lzpqdetywa(yxxsbfzwwc) = dhpsepalxs yfrhcscbwa (phkgbchbce, zibfjcnadd - tzxsyppols) View more | ||||||
Phase 1 | 96 | TDV-1+TDV (Low Dose Subcutaneous: TDV) | fupymzqzkw(rzsjqsqeez) = xqnshzcxjd ykqtdlbiir (aprwxbadfg, aoseqvqnde - pthzuwwamu) View more | - | 27 Feb 2017 | ||
placebo+TDV (Low Dose Subcutaneous: Placebo) | fupymzqzkw(rzsjqsqeez) = ovhucwkqij ykqtdlbiir (aprwxbadfg, utvtpalcje - pkxqjdvhfj) View more |